Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease

BACKGROUND: A single-daily dose of 75 mg of acetylsalicylic acid inhibits 100% of thromboxane-B2 synthesis within 30–60 min. Thromboxane-B2 synthesis then recovers slowly as new platelets are released from the bone marrow. Normally, only 10% of the platelets are replaced daily by new platelets enter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegde, Nischal N., Mathew, Navin, Thachathodiyl, Rajesh, Menon, Jaideep C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551163/
https://www.ncbi.nlm.nih.gov/pubmed/36237906
http://dx.doi.org/10.3389/fcvm.2022.1004473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551163/
https://www.ncbi.nlm.nih.gov/pubmed/36237906
http://dx.doi.org/10.3389/fcvm.2022.1004473

Ejemplares similares